Recent 8-K filings for USAQ

• May 26, 2026, 8:30 AM ET other material materiality 0.60 positive item 7.01item 9.01

  QHSLab reports April 2026 unaudited revenue of $325,889, up 57% YoY; launches QHS Practice Access Network

  Unaudited April 2026 revenue $325,889, up 57% from $207,538 in April 2025.

• April 21, 2026, 7:59 PM ET earnings materiality 0.65 positive item 7.01item 9.01

  QHSLab reports 127% YoY ISP revenue growth to $370K in Q1 2026; launches GLP-1 support program

  Unaudited Q1 2026 ISP revenue of $370,000, up 127% from $163,000 in Q1 2025.

• March 31, 2026, 7:59 PM ET earnings materiality 0.70 positive item 7.01item 9.01

  QHSLab reports fiscal 2025 net income of $457K, revenue up 26% to $2.69M

  Revenue $2.69M (+26% YoY); net income $457,417 vs net loss $259,239 in 2024.

• January 26, 2026, 6:59 PM ET earnings materiality 0.75 positive item 7.01item 9.01

  QHSLab reports preliminary 2025 revenue up 25% to $2.68M, debt cut to $20k

  Revenue $2,676,074, up 25% YoY; gross profit $1,795,182, up 32% YoY.

• January 16, 2026, 6:59 PM ET other material materiality 0.65 positive item 7.01item 9.01

  QHSLab initiates board expansion to add independent directors; convertible debt eliminated

  Process to add independent board members commenced; interviews and meetings with candidates underway.

• January 6, 2026, 6:59 PM ET other material materiality 0.65 positive item 7.01item 9.01

  QHSLab reports 32% revenue growth to $1.99M, eliminates most convertible debt, cash ~$630k

  Revenue $1.99M for nine months ended Sep 30, 2025 (+32% YoY); gross margin 66%.

• December 29, 2025, 6:59 PM ET other material materiality 0.70 positive item 1.01item 3.02item 7.01item 9.01 ◈ Material Agreements

  QHSLab raises $500K in equity, retires $1.4M convertible debt; clean balance sheet entering 2026

  Private placement of 1,666,663 shares at $0.30/share plus 416,666 warrants exercisable at $0.60 through Dec 2030.

• November 24, 2025, 6:59 PM ET other material materiality 0.75 positive item 7.01item 9.01

  QHSLab nine-month revenue $1.99M; retires convertible notes, eliminates dilution overhang

  Nine-month 2025 revenue $1.99M, up 32% YoY from $1.51M; gross profit $1.32M.

• November 18, 2025, 6:59 PM ET earnings materiality 0.75 positive item 1.01item 2.04item 7.01item 9.01 ◈ Debt Financings

  QHSLab retires $1.4M in convertible notes for $300K; Q3 revenue up 35% to $737K

  Repurchased and cancelled $1.4M+ in defaulted convertible notes for $300K cash; conversion rights at $0.20/share eliminated.

• July 8, 2025, 7:59 PM ET other material materiality 0.60 positive item 7.01item 9.01

  QHSLab (USAQ) opens first co-branded behavioral health center in Miami with QHS Healthcare

  First QHS Behavioral Healthcare Center (QBHC) opened in Miami on July 8, 2025, in partnership with Global Behavioral Healthcare Group Corp.

• May 15, 2025, 7:59 PM ET earnings materiality 0.65 positive item 7.01item 9.01

  QHSLab Q1 revenue up 32% to $645K; gross margin expands to 66.6%

  Total revenue $645,419 vs $488,587 in Q1 2024, a 32.1% increase.

• February 25, 2025, 6:59 PM ET other material materiality 0.85 negative item 2.04item 9.01

  QHSLab receives $1.4M default notice on two convertible notes; expects not to pay by Feb 27

  Received Notice of Default from Mercer Street Global Opportunity Fund for two secured promissory notes (August 2021 and July 2022).

• February 18, 2025, 6:59 PM ET earnings materiality 0.65 positive item 7.01item 9.01

  QHSLab reports 98% Q4 revenue surge, first profitable year with net income of $69,188

  Q4 revenue $625,981 (+98% YoY); net income $40,838 vs loss $86,627 Q4 2023.

• November 25, 2024, 6:59 PM ET other material materiality 0.65 positive item 7.01item 9.01

  QHSLab reports Oct sales up 110% to $225k; APA abstracts accepted for 2025

  October 2024 unaudited sales ~$225,000, a 110% increase YoY; annualized run rate $2.7M.

• November 14, 2024, 6:59 PM ET earnings materiality 0.65 positive item 7.01item 9.01

  QHSLab Q3 revenue up 62% to $544K, net income $49.8K, gross margin 67.1%

  Revenue $544,285 (+62% YoY); gross margin 67.1% (up from 56.3%). Net income $49,765 vs ($82,000) loss in Q3 2023.

• October 21, 2024, 7:59 PM ET other material materiality 0.65 positive item 7.01item 9.01

  QHSLab reports 40% revenue growth, positive cash flow, and strategic review

  Revenue increased 40% year-over-year to over $1.5 million in the third quarter of 2024.

• September 25, 2024, 7:59 PM ET other material materiality 0.65 positive item 7.01item 9.01

  QHSLab secures $297K grant from global consumer health firm for allergic rhinitis digital study

  QHSLab received $297,360 grant from a Global Leader in Consumer Health to advance digital medicine for allergic rhinitis.

• August 14, 2024, 7:59 PM ET earnings materiality 0.75 positive item 7.01item 9.01

  QHSLab reports strong Q2 2024: revenue +17%, gross margin 62.2%, net loss down 97% to $2.9K

  Q2 revenue $473,073 (+17% YoY); six-month revenue $961,660 (+27%).

• June 7, 2024, 7:59 PM ET other material materiality 0.75 negative item 4.01item 9.01

  QHSLab dismisses auditor Accell, engages Astra; prior reports included going concern uncertainty

  Dismissed Accell Audit & Compliance as independent auditor effective June 4, 2024.

• May 13, 2024, 7:59 PM ET earnings materiality 0.65 positive item 7.01item 9.01

  QHSLab Q1 revenue up 39% to $488K; posts positive operating income of $13.6K vs loss of $120.8K year ago

  Q1 2024 revenue $488,587 (+38.6% YoY); Integrated Service Program revenue surged 268% to $127,004.

• April 26, 2024, 7:59 PM ET earnings materiality 0.65 positive item 7.01item 9.01

  QHSLab reports preliminary Q1 revenue $488,587, up 38% YoY; gross profit $286,157, up 53%

  Revenue of $488,587, up 38% from $352,799 in Q1 2023.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.60 · Most common event other_material

25 positive 2 negative 12 neutral

source · USAQ on sec.gov